Weekend reads: Why authors keep citing retracted studies; patients over papers; final ruling in Hwang case
- Why do researchers keep citing retracted papers? In Quartz, Keith Collins analyzes our top-cited retracted papers list.
- “There is something rotten in the state of science,” writes Pierre Barthélémy in Le Monde, rounding up news of recent fake peer review retractions (in French).
- South Korea’s Supreme Court has “ruled that the dismissal of disgraced stem cell scientist Hwang Woo-suk by Seoul National University was legal,” KBS reports.
- Philip Moriarty comes “not to pillory, but to praise the [Engineering and Physics Sciences Research Council] for its stance on impact.”
- Prioritize patients above papers, says Nobelist Shinya Yamanaka.
- Should all scientific papers be anonymous? Our latest STAT column.
- Is biomedical research a house of cards? Gerald Lushington — who was censured by the U.S. Office of Research Integrity four years ago — and Rathnam Chaguturu take a look (sub req’d).
- A look at citation patterns for economics papers, via Andrew Gelman.
- Jeffrey Beall has some insights about Insight Medical Publishing, and they’re not good.
- The U.S. NSF should be willing to fund grants that are likely to fail, says The Grumpy Geophysicist.
- “Some publishers add new journal titles more often than I buy new shoes,” says Science editor-in-chief Marcia McNutt. We wonder who she could possibly be talking about…
- “Retractions, Post-Publication Peer Review, and Fraud: Scientific Publishing’s Wild West.” A report on co-founder Ivan Oransky’s McGovern Address to the American Medical Writers Association.
- “Science journalists are not science advocates,” writes Brooke Borel in The Guardian. “And scientists aren’t science.”
- “Tissues from millions of Americans are used in research without their knowledge,” writes Rebecca Skloot in The New York Times.
- “How researchers dupe the public with a sneaky practice called ‘outcome switching.’” Vox’s Julia Belluz talks to Ben Goldacre about the Compare Project.
- Should the US National Library of Medicine index anti-choice journals? asks Jen Gunter.
- “Silicon Valley is confusing pseudo-science with innovation,” say Elizabeth Lopatto and Ben Popper in The Verge.
- “A tiny Canadian company and a powerful U.S. government research agency are locked in an unusual spat over the safety of a popular anti-blindness supplement, amid accusations both sides’ scientific opinions are tainted by commercial interests,” the National Post reports.
- There’s a fine line between quality improvement and medical research, says David Gorski.
- Here were the most ridiculous health claims of 2015, according to Julia Belluz of of Vox.
- Eighteen of the 180 original signers of a letter requesting the retraction of a corrected BMJ investigative feature are not listed on an updated version, Peter Heimlich reports.
Retractions Outside of The Scientific Literature
- “Nigerian Tribune Issues Retraction And Apology Over Purported Interview With Professor Sagay.” Just because someone answers the phone doesn’t mean they’re who you thought they were.
- This year’s unsung newsmaker? The delete key, says Bob Mackin of The Tyee.
- The lawyer for two baseball players is demanding that Al Jazeera retract a report that they used performance-enhancing drugs.
Like Retraction Watch? Consider making a tax-deductible contribution to support our growth. You can also follow us on Twitter, like us on Facebook, add us to your RSS reader, and sign up on our homepage for an email every time there’s a new post. Click here to review our Comments Policy.